Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 1171 AL 1185

GBA, Gaucher Disease, and Parkinson's Disease: From Genetic to Clinic to New Therapeutic Approaches

Riboldi GM, Di Fonzo AB.

Cells. 2019 Apr 19;8(4):364. doi: 10.3390/cells8040364.

A novel wireless brain stimulation device for long-term use in freely moving mice

Alpaugh M, Saint-Pierre M, Dubois M, Aubé B, Arsenault D, Kriz J, Cicchetti A, Cicchetti F.

Sci Rep. 2019 Apr 23;9(1):6444. doi: 10.1038/s41598-019-42910-7.

Astrocyte alterations in neurodegenerative pathologies and their modeling in human induced pluripotent stem cell platforms

Oksanen M, Lehtonen S, Jaronen M, Goldsteins G, Hämäläinen RH, Koistinaho J.

Cell Mol Life Sci. 2019 Jul;76(14):2739-2760. doi: 10.1007/s00018-019-03111-7. Epub 2019 Apr 23.

Effect of virtual reality on balance and gait ability in patients with Parkinson's disease: a systematic review and meta-analysis

Wang B, Shen M, Wang YX, He ZW, Chi SQ, Yang ZH.

Clin Rehabil. 2019 Jul;33(7):1130-1138. doi: 10.1177/0269215519843174. Epub 2019 Apr 24.

Pharmacokinetics of monoamine oxidase B inhibitors in Parkinson's disease: current status

Müller T, Möhr JD.

Expert Opin Drug Metab Toxicol. 2019 May;15(5):429-435. doi: 10.1080/17425255.2019.1607292. Epub 2019 Apr 24.

Microglial histamine H(4)R in the pathophysiology of Parkinson's disease-a new actor on the stage?

Schneider EH.

Naunyn Schmiedebergs Arch Pharmacol. 2019 Jun;392(6):641-645. doi: 10.1007/s00210-019-01635-0. Epub 2019 Apr 24.

Extensive validation study of the Parkinson's Disease Composite Scale

Martinez-Martin P, Radicati FG, Rodriguez Blazquez C, Wetmore J, Kovacs N, Ray Chaudhuri K, Stocchi F; PDCS European Study Group.

Eur J Neurol. 2019 Oct;26(10):1281-1288. doi: 10.1111/ene.13976. Epub 2019 May 31.

Safety and preliminary efficacy of intranasal insulin for cognitive impairment in Parkinson disease and multiple system atrophy: A double-blinded placebo-controlled pilot study

Novak P, Pimentel Maldonado DA, Novak V.

PLoS One. 2019 Apr 25;14(4):e0214364. doi: 10.1371/journal.pone.0214364. eCollection 2019.

Proteomics; applications in familial Parkinson's disease

Li Y, Cookson MR.

J Neurochem. 2019 Nov;151(4):446-458. doi: 10.1111/jnc.14708. Epub 2019 Jul 9.

MicroRNAs in Neuroinflammation: Implications in Disease Pathogenesis, Biomarker Discovery and Therapeutic Applications

Slota JA, Booth SA.

Noncoding RNA. 2019 Apr 24;5(2):35. doi: 10.3390/ncrna5020035.

Validation and reliability study of the Turkish version of the Neuroquality of Life (Neuro-QoL)-Stigma Scale for neurological disorders

Karşıdağ S, Çınar N, Şahin Ş, Kotevoğlu N, Ateş MF.

Turk J Med Sci. 2019 Jun 18;49(3):789-794. doi: 10.3906/sag-1811-50.

Phosphoregulation on mitochondria: Integration of cell and organelle responses

Lucero M, Suarez AE, Chambers JW.

CNS Neurosci Ther. 2019 Jul;25(7):837-858. doi: 10.1111/cns.13141. Epub 2019 Apr 25.

Play in advance against neurodegeneration: exploring enteric glial cells in gut-brain axis during neurodegenerative diseases

Seguella L, Capuano R, Sarnelli G, Esposito G.

Expert Rev Clin Pharmacol. 2019 Jun;12(6):555-564. doi: 10.1080/17512433.2019.1612744. Epub 2019 May 6.

Levodopa imparts a normalizing effect on default-mode network connectivity in non-demented Parkinson's disease

Zhong J, Guan X, Zhong X, Cao F, Gu Q, Guo T, Zhou C, Zeng Q, Wang J, Gao T, Zhang M.

Neurosci Lett. 2019 Jul 13;705:159-166. doi: 10.1016/j.neulet.2019.04.042. Epub 2019 Apr 23.

Initial evaluation and management of wide-complex tachycardia: A simplified and practical approach

Littmann L, Olson EG, Gibbs MA.

Am J Emerg Med. 2019 Jul;37(7):1340-1345. doi: 10.1016/j.ajem.2019.04.027. Epub 2019 Apr 12.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias